STOCKS | Island Pharmaceuticals Jumps After Emergency-Use Approval for Ebola Drug
2026-07-07 01:10:29
Australia’s Island Pharmaceuticals Ltd. surged as much as 47% after saying its experimental antiviral galidesivir secured regulatory and ethics approvals for emergency use in patients with the Bundibugyo strain of Ebola in Uganda, according to Bloomberg.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
